Security key
75886F107
REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN)
CUSIP: 75886F107
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 91,348,974
- Total 13F value
- $80,250,681,450
- Share change
- +171,553
- Put/Call ratio
- 143%
- SEC-reported price per share
- $878.29
- Number of holders
- 1,264
- Value change
- +$167,710,733
- Number of buys
- 542
- Number of sells
- 507
- Shares outstanding
- 103,945,862
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
1,264
Top holders
10
REGN full security history
Ownership snapshot
Full 13F holder table
REGENERON PHARMACEUTICALS, INC. SEC filings
REGENERON PHARMACEUTICALS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
30 Sep 2023
13F
Highest disclosed value: $8,098,660,565
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC has the largest disclosed position value at $8.1B.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Disclosed position value
Top 5
FMR LLC
$8.1B
BlackRock Finance, Inc.
$7.3B
VANGUARD GROUP INC
$7.24B
JPMORGAN CHASE & CO
$6.08B
Capital World Investors
$4.2B
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$8,098,660,565
9,840,892 shares
|
— | 30 Sep 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$7,304,024,458
8,875,309 shares
|
— | 30 Sep 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$7,240,817,675
8,798,505 shares
|
— | 30 Sep 2023 |
| JPMORGAN CHASE & CO |
13F
Company
|
—
denominator unverified
|
$6,080,978,687
7,389,154 shares
|
— | 30 Sep 2023 |
| Capital World Investors |
13F
Company
|
—
denominator unverified
|
$4,203,195,548
5,107,339 shares
|
— | 30 Sep 2023 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$3,974,161,074
4,829,106 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1,264
Shares
91,348,974
Rows available
1,264
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
1,169
Q4 2023 holders
1,264
Holder diff
95
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|